Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-012289
Filing Date
2016-01-27
Accepted
2016-01-27 21:19:29
Documents
1
Period of Report
2016-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3952
  Complete submission text file 0000899243-16-012289.txt   5414
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC. 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Barrett Peter (Reporting) CIK: 0001291895 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36510 | Film No.: 161366438

Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Issuer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations